Sohrab Boozarpour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sohrab Boozarpour has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Reza Bahrami
Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran
4 shared publications - Maryam Moghaddam Matin
Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran
4 shared publications - Sajjad Sisakhtnezhad
Department of biology, Faculty of science, Razi University, Kermanshah, Iran
4 shared publications Mina Lashkarboloki
Dr. Fahimi Medical Laboratory, Gonbad Kavous, Golestan, Iran
3 shared publications- Moein Farshchian
Stem Cell and Regenerative Medicine Research Group, Academic Center for Education, Culture and Research (ACECR), Khorasan Razavi, Mashhad, Iran
3 shared publications Eisa Jorjani
Assistant Professor, Department of Biology, Faculty of Basic Sciences, Gonbad kavous University, Gonbad kavous, Golestan, Iran
2 shared publications
Latest Publications
- 7 April 2026
- Published by Springer Nature in Biochemical Genetics
- Vol. 64 (5) , 6922-6936
A Novel Serum miRNA Panel (miR-145, miR-34a, and miR-222) for Schwannoma Diagnosis
- 7 April 2026
- Published by Springer Nature in Biochemical Genetics
- Vol. 64 (5) , 6922-6936
A Novel Serum miRNA Panel (miR-145, miR-34a, and miR-222) for Schwannoma Diagnosis
- 24 February 2026
- Published by Springer Nature in Biologia
- Vol. 81 (3) , 74
Potential of Dracocephalum kotschyi essential oil in targeting biofilm in XDR-CRAB Acinetobacter baumannii
- 24 February 2026
- Published by Springer Nature in Biologia
- Vol. 81 (3) , 74
Potential of Dracocephalum kotschyi essential oil in targeting biofilm in XDR-CRAB Acinetobacter baumannii
- 20 December 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 212, 108256
Salvia abrotanoides leaves and flowers essential oils inhibit the quorum-sensing system of extensively drug-resistant (XDR) Acinetobacter baumannii
- 20 December 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 212, 108256
Salvia abrotanoides leaves and flowers essential oils inhibit the quorum-sensing system of extensively drug-resistant (XDR) Acinetobacter baumannii
- 19 July 2025
- Published by Springer Nature in Diabetology International
- Vol. 16 (4) , 698-706
Association of the vaspin gene rs2236242 and chemerin gene rs17173608 variants with type 2 diabetes mellitus in Northeast Iran: a case‒control study
Type 2 diabetes is a complex metabolic disorder caused by a combination of genetic and nongenetic factors. Obesity is one of the main causes of diabetes, and adipose tissue releases different adipokines that regulate glucose and lipid metabolism. Genetic changes in adipokines can reduce their expression or function. The aim of this study was to investigate the associations between the rs2236242 and rs17173608 variants in vaspin and chemerin adipokines and susceptibility to type 2 diabetes and obesity in the northeastern population of Iran. This case‒control study included 200 T2DM patients and 200 healthy controls. After DNA extraction, the vaspin rs2236242 and chemerin rs17173608 gene variants were analyzed via tetra-ARMS-PCR. Genotyping revealed that the TT genotype of the rs2236242 vaspin and the GG and TG genotypes of the rs17173608 chemerin are associated with susceptibility to type 2 diabetes, and there was a strong correlation between a higher risk of type 2 diabetes and the recessive model of TT vs. GG + TG of chemerin. In addition, the TT and TA genotypes of the rs2236242 vaspin in diabetic and normal individuals were significantly associated with overweight and obesity but did not significantly differ between the rs17173608 variant and the BMI. This study demonstrated that the TT genotype of vaspin and the TG and GG genotypes of chemerin may increase the risk of diabetes, and the TT genotype of vaspin is significantly associated with obesity. These results suggest that changing lifestyles might help prevent T2DM in genetically high-risk individuals.
- 19 July 2025
- Published by Springer Nature in Diabetology International
- Vol. 16 (4) , 698-706
Association of the vaspin gene rs2236242 and chemerin gene rs17173608 variants with type 2 diabetes mellitus in Northeast Iran: a case‒control study
Type 2 diabetes is a complex metabolic disorder caused by a combination of genetic and nongenetic factors. Obesity is one of the main causes of diabetes, and adipose tissue releases different adipokines that regulate glucose and lipid metabolism. Genetic changes in adipokines can reduce their expression or function. The aim of this study was to investigate the associations between the rs2236242 and rs17173608 variants in vaspin and chemerin adipokines and susceptibility to type 2 diabetes and obesity in the northeastern population of Iran. This case‒control study included 200 T2DM patients and 200 healthy controls. After DNA extraction, the vaspin rs2236242 and chemerin rs17173608 gene variants were analyzed via tetra-ARMS-PCR. Genotyping revealed that the TT genotype of the rs2236242 vaspin and the GG and TG genotypes of the rs17173608 chemerin are associated with susceptibility to type 2 diabetes, and there was a strong correlation between a higher risk of type 2 diabetes and the recessive model of TT vs. GG + TG of chemerin. In addition, the TT and TA genotypes of the rs2236242 vaspin in diabetic and normal individuals were significantly associated with overweight and obesity but did not significantly differ between the rs17173608 variant and the BMI. This study demonstrated that the TT genotype of vaspin and the TG and GG genotypes of chemerin may increase the risk of diabetes, and the TT genotype of vaspin is significantly associated with obesity. These results suggest that changing lifestyles might help prevent T2DM in genetically high-risk individuals.
- Open Access
- 1 April 2025
- Published by National Academy of Sciences of Tajikistan in Reports of Biochemistry and Molecular Biology
- Vol. 14 (1) , 85-94
Metformin Increased Histone Deacetylases 1, 3, and 8 Expressions as Epigenetic Regulators in Type 2 Diabetic Patients
Type 2 diabetes is a complex disease resulting from interactions between genetic, epigenetic, and environmental factors. Histone deacetylases (HDAC) are essential epigenetic-regulatory enzymes that affect gene expression and, through metabolic homeostasis and beta-cell function regulation, play significant roles in the development and treatment of diabetes. In this study, we specifically focused on the effect of metformin, the first-line therapy for type 2 diabetes on the expression of class I HDAC genes. A total of 60 patients were equally allocated into two groups: those receiving metformin treatment and those without treatment. Also, 60 subjects with normal glucose tolerance were divided into two groups: non-obese (n=30) and obese individuals (n=30). All biochemical and clinical factors were estimated using standard methods, and RT-qPCR was used to quantify the expression levels of the candidate genes in peripheral blood mononuclear cells of different groups. The metformin treatment group exhibited increased expression of HDAC1, HDAC3, and HDAC8 in comparison to the non-treatment group. Furthermore, the expression levels of HDAC 1, 2, and 3 were higher in the obese group than the non-obese. Interestingly, evaluation of biochemical and clinical factors revealed significant association between the expression of class I HDAC genes and several diabetes-related risk factors. The current findings suggest that HDAC1, 3, and 8 genes expression are affected by metformin, and obesity has a substantial ability to increase the risk of diabetes. However, changes in HDAC expression may represent potential biomarkers and therapeutic targets for future clinical studies in diabetes, particularly in exploring combination therapies involving histone deacetylase inhibitors and metformin.
- 1 April 2025
- Published by National Academy of Sciences of Tajikistan in Reports of Biochemistry and Molecular Biology
- Vol. 14 (1) , 85-94
Open AccessMetformin Increased Histone Deacetylases 1, 3, and 8 Expressions as Epigenetic Regulators in Type 2 Diabetic Patients
Type 2 diabetes is a complex disease resulting from interactions between genetic, epigenetic, and environmental factors. Histone deacetylases (HDAC) are essential epigenetic-regulatory enzymes that affect gene expression and, through metabolic homeostasis and beta-cell function regulation, play significant roles in the development and treatment of diabetes. In this study, we specifically focused on the effect of metformin, the first-line therapy for type 2 diabetes on the expression of class I HDAC genes. A total of 60 patients were equally allocated into two groups: those receiving metformin treatment and those without treatment. Also, 60 subjects with normal glucose tolerance were divided into two groups: non-obese (n=30) and obese individuals (n=30). All biochemical and clinical factors were estimated using standard methods, and RT-qPCR was used to quantify the expression levels of the candidate genes in peripheral blood mononuclear cells of different groups. The metformin treatment group exhibited increased expression of HDAC1, HDAC3, and HDAC8 in comparison to the non-treatment group. Furthermore, the expression levels of HDAC 1, 2, and 3 were higher in the obese group than the non-obese. Interestingly, evaluation of biochemical and clinical factors revealed significant association between the expression of class I HDAC genes and several diabetes-related risk factors. The current findings suggest that HDAC1, 3, and 8 genes expression are affected by metformin, and obesity has a substantial ability to increase the risk of diabetes. However, changes in HDAC expression may represent potential biomarkers and therapeutic targets for future clinical studies in diabetes, particularly in exploring combination therapies involving histone deacetylase inhibitors and metformin.
- Open Access
- 18 February 2024
- Published by Knowledge E DMCC in International Journal of Reproductive BioMedicine (IJRM)
- Vol. 22 (1) , 61-68
The genetically modified human foreskin fibroblast cell line (YhFF#8) stably expressing Cas9 gene: A lab resource report
Background: Stable Cas9 (CRISPR-associated protein 9)-expressing cell lines have emerged as valuable tools in genetic research, enhancing the efficiency of the CRISPR/Cas9 system and streamlining gene editing procedures. These cell lines enable simultaneous editing of multiple genes and reduce the overall editing time. Objective: This study aimed to develop a stable human fibroblast cell line capable of genetic conversion into a mutant form, serving as a cellular model for a specific genetic disease. The established cell line facilitates investigation of disease mechanisms, testing of potential treatments, and gaining insights into underlying molecular processes. Materials and Methods: Human embryonic kidney 293LTV cells were used to produce pseudo-virus particles, while Yazd human foreskin fibroblasts batch 8 (YhFF#8) cells were targeted for genetic modification. Transfection of human embryonic kidney 293LTV cells with pCDH-Cas9 plasmid DNA generated pseudo-viral particles. YhFF#8 cells were transduced and selected using antibiotics. Green fluorescent protein (GFP) detection confirmed successful transduction and selection. Relative expression levels of the Cas9 gene were determined by quantitative polymerase chain reaction. Results: The study validated the fidelity of the Cas9 gene cassette sequence and its transcriptional activity. Transduced YhFF#8 cells exhibited green fluorescence, with antibiotic selection resulting in nearly 100% transduced cells. A reporter GFP gene enabled real-time monitoring of YhFF#8-Cas9-GFP-PuroR cells using fluorescence microscopy. Conclusion: YhFF#8-Cas9-GFP-PuroR cells, labeled and susceptible to genomic editing, provide an optimal source for generating induced pluripotent stem cell lines for future biomedical research. Key words: Fibroblasts, Cell line, Genetic transduction, CRISPR-Cas9.
- 18 February 2024
- Published by Knowledge E DMCC in International Journal of Reproductive BioMedicine (IJRM)
- Vol. 22 (1) , 61-68
Open AccessThe genetically modified human foreskin fibroblast cell line (YhFF#8) stably expressing Cas9 gene: A lab resource report
Background: Stable Cas9 (CRISPR-associated protein 9)-expressing cell lines have emerged as valuable tools in genetic research, enhancing the efficiency of the CRISPR/Cas9 system and streamlining gene editing procedures. These cell lines enable simultaneous editing of multiple genes and reduce the overall editing time. Objective: This study aimed to develop a stable human fibroblast cell line capable of genetic conversion into a mutant form, serving as a cellular model for a specific genetic disease. The established cell line facilitates investigation of disease mechanisms, testing of potential treatments, and gaining insights into underlying molecular processes. Materials and Methods: Human embryonic kidney 293LTV cells were used to produce pseudo-virus particles, while Yazd human foreskin fibroblasts batch 8 (YhFF#8) cells were targeted for genetic modification. Transfection of human embryonic kidney 293LTV cells with pCDH-Cas9 plasmid DNA generated pseudo-viral particles. YhFF#8 cells were transduced and selected using antibiotics. Green fluorescent protein (GFP) detection confirmed successful transduction and selection. Relative expression levels of the Cas9 gene were determined by quantitative polymerase chain reaction. Results: The study validated the fidelity of the Cas9 gene cassette sequence and its transcriptional activity. Transduced YhFF#8 cells exhibited green fluorescence, with antibiotic selection resulting in nearly 100% transduced cells. A reporter GFP gene enabled real-time monitoring of YhFF#8-Cas9-GFP-PuroR cells using fluorescence microscopy. Conclusion: YhFF#8-Cas9-GFP-PuroR cells, labeled and susceptible to genomic editing, provide an optimal source for generating induced pluripotent stem cell lines for future biomedical research. Key words: Fibroblasts, Cell line, Genetic transduction, CRISPR-Cas9.
- 1 June 2020
- Published by CMV Verlag in Alborz University Medical Journal
- Vol. 9 (3) , 287-294
Association Study of miR-124-a-3 Gene rs34059726 Polymorphism with Prostate Cancer in Gonbad Kavous
- 1 June 2020
- Published by CMV Verlag in Alborz University Medical Journal
- Vol. 9 (3) , 287-294
Association Study of miR-124-a-3 Gene rs34059726 Polymorphism with Prostate Cancer in Gonbad Kavous
- 25 May 2020
- Published by University of Szeged in Acta Biologica Szegediensis
- Vol. 63 (2) , 91-101
Micromorphological, anatomical and molecular study of Hedera species (Araliaceae) in Iran
Hedera, with 12 extant species, is a genus of evergreen climbers native to Europe, north Africa, and south Asia. In this study, the micromorphological, anatomical structure and molecular evidences of 11 populations from two species of Hedera (H. helix and H. pastuchovii) have been considered to evaluate the relationships in Hedera. In total, seven quantitative and qualitative characters of pollen were selected and measured. Based on this study, the anticlinal wall and surface sculpturing of seed support for separation of two species of Hedera. Micromorphology of epidermis illustrated two types of epidermal cells: puzzle-shaped and polygonal cells. Using nuclear (nrDNA ITS) marker, we reconstructed phylogenetic relationships within two species of Hedera. This data set was analyzed by phylogenetic methods including Bayesian inference, maximum likelihood, and maximum parsimony. In phylogenetic analyses, all members of two species formed a well-supported clade (PP = 1; ML/BS = 100/100) and divided into two major clades (A and B). Neighbor Net diagram demonstrated separation of the studied populations. The results showed that these taxa differ in taxonomically important micromorphological, anatomical and molecular characteristics and these data provide reliable evidence for separation of these two species.
- 25 May 2020
- Published by University of Szeged in Acta Biologica Szegediensis
- Vol. 63 (2) , 91-101
Micromorphological, anatomical and molecular study of Hedera species (Araliaceae) in Iran
Hedera, with 12 extant species, is a genus of evergreen climbers native to Europe, north Africa, and south Asia. In this study, the micromorphological, anatomical structure and molecular evidences of 11 populations from two species of Hedera (H. helix and H. pastuchovii) have been considered to evaluate the relationships in Hedera. In total, seven quantitative and qualitative characters of pollen were selected and measured. Based on this study, the anticlinal wall and surface sculpturing of seed support for separation of two species of Hedera. Micromorphology of epidermis illustrated two types of epidermal cells: puzzle-shaped and polygonal cells. Using nuclear (nrDNA ITS) marker, we reconstructed phylogenetic relationships within two species of Hedera. This data set was analyzed by phylogenetic methods including Bayesian inference, maximum likelihood, and maximum parsimony. In phylogenetic analyses, all members of two species formed a well-supported clade (PP = 1; ML/BS = 100/100) and divided into two major clades (A and B). Neighbor Net diagram demonstrated separation of the studied populations. The results showed that these taxa differ in taxonomically important micromorphological, anatomical and molecular characteristics and these data provide reliable evidence for separation of these two species.
- Open Access
- 1 March 2020
- Vol. 11 (2) , 82-89
Evaluation of IFN-γ and T-bet Expression Levels as Possible Molecular Markers of Schizophrenia
- 1 March 2020
- Vol. 11 (2) , 82-89
Open AccessEvaluation of IFN-γ and T-bet Expression Levels as Possible Molecular Markers of Schizophrenia
- Open Access
- 1 July 2019
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 12, 5601-5607
miR-21: a promising biomarker for the early detection of colon cancer
Purpose: The aim of this study was to compare the expression of miR-21 gene in stages II-IV of formalin-fixed paraffin-embedded (FFPE) tissue in patients with colon cancer and introduce miR-21 as a potential molecular marker for detection of colon cancer in the early stages. Introduction: Currently, identification of key molecules involved in the pathogenesis of cancer is one of the areas under consideration. miRNAs, are small RNAs which have been identified in many cancers. In this study, we investigated the expression of miR-21 in three pathologic stages in patients with colon cancer in the north of Iran. Patients and methods: A total of 40 FFPE samples were obtained from patients with stages II, III, and IV from hospitals in Mazandaran and Golestan provinces. After extraction of RNA, treatment with DNase I and cDNA synthesis was performed and miR-21 expression was assessed by qPCR. Then, the data were analyzed using statistical software R (3.4.3). Results: The expression of miR-21 in stage II was significantly different from stage IV. However, no significant difference was observed between the other stages. In stage II, the level of miR-21 expression was higher in men than women. Moreover, in the second pathological stage, miR-21 expression was reduced in patients with adjacent lymphoid tissue engagement. In addition, the expression of miR-21 in grade I was significantly higher than grade II. Conclusion: The results of this study suggest that miR-21 can be a diagnostic marker for early stages of colon cancer, especially in men. It can also be considered as a good candidate for targeted treatment of colon cancer in the early stages of the disease. Furthermore, for the first time, we suggested that miR-21 can be a good molecular marker for classification of the stages of colon cancer.
- 1 July 2019
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 12, 5601-5607
Open AccessmiR-21: a promising biomarker for the early detection of colon cancer
Purpose: The aim of this study was to compare the expression of miR-21 gene in stages II-IV of formalin-fixed paraffin-embedded (FFPE) tissue in patients with colon cancer and introduce miR-21 as a potential molecular marker for detection of colon cancer in the early stages. Introduction: Currently, identification of key molecules involved in the pathogenesis of cancer is one of the areas under consideration. miRNAs, are small RNAs which have been identified in many cancers. In this study, we investigated the expression of miR-21 in three pathologic stages in patients with colon cancer in the north of Iran. Patients and methods: A total of 40 FFPE samples were obtained from patients with stages II, III, and IV from hospitals in Mazandaran and Golestan provinces. After extraction of RNA, treatment with DNase I and cDNA synthesis was performed and miR-21 expression was assessed by qPCR. Then, the data were analyzed using statistical software R (3.4.3). Results: The expression of miR-21 in stage II was significantly different from stage IV. However, no significant difference was observed between the other stages. In stage II, the level of miR-21 expression was higher in men than women. Moreover, in the second pathological stage, miR-21 expression was reduced in patients with adjacent lymphoid tissue engagement. In addition, the expression of miR-21 in grade I was significantly higher than grade II. Conclusion: The results of this study suggest that miR-21 can be a diagnostic marker for early stages of colon cancer, especially in men. It can also be considered as a good candidate for targeted treatment of colon cancer in the early stages of the disease. Furthermore, for the first time, we suggested that miR-21 can be a good molecular marker for classification of the stages of colon cancer.